tesa Labtec Attends 2014 AAPS Annual Meeting and Exposition

LANGENFELD, Germany--()--tesa Labtec, the pharmaceutical specialist for the development and production of film-shaped dosage forms such as transdermal patches as well as oral and buccal films, announces its attendance at the “2014 AAPS Annual Meeting and Exposition” in San Diego.

The AAPS is the biggest scientific exhibition is the US and constitutes a promising platform in order to present tesa Labtec’s capabilities to the pharmaceutical industry.

tesa Labtec has a proven track record in bringing customer molecules to the market (e.g. Europe’s no 1 generic fentanyl patch or Setofilm (ondansetron), the first ever approved Rx orodispersible film). The company will inform interested companies and scientists about its proprietary technologies like Transfilm®, Rapidfilm® and Mucofilm® but also about its contract development & manufacturing (CDMO) services.

Moreover, tesa Labtec intends to use this exhibition to introduce pharma representatives to its new LabFactory - a fully automated R&D pilot production facility for the manufacture of oral films and patches during early stage development and for phase I and II clinical trials. The LabFactory is the ideal supplement to the already available state of the art large-scale manufacturing site.

tesa Labtec and its team would be happy to welcome interested companies at its booth (Nr. 648) in San Diego.

If you are interested in arranging a meeting beforehand, please use the contact details provided below.

About tesa Labtec GmbH

With more than 20 years of experience, tesa Labtec is one of the leading drug delivery companies for film-shaped dosage forms like patches and oral films. Based on its innovative Transfilm®, Rapidfilm®, and Mucofilm® technologies, the company offers contract development and state-of-the-art contract manufacturing for transdermal and topical patch products as well as oral dissolvable and transmucosal films. tesa Labtec is a wholly owned subsidiary of tesa SE, a member of the Beiersdorf group of companies, and represents the pharmaceutical business in a truly global family of companies offering “Solutions for Pharma.”

For press releases and other company information visit: www.tesa-labtec.com

Contacts

tesa Labtec GmbH
Klaus Koehl
E-mail: klaus.koehl@tesa.com
Phone: 0049(0)2173-973516

Release Summary

tesa Labtec, the pharmaceutical specialist within development and production of transdermal patches as well as oral and buccal films, will attend this year´s AAPS Meeting and Exposition in San Diego.

Contacts

tesa Labtec GmbH
Klaus Koehl
E-mail: klaus.koehl@tesa.com
Phone: 0049(0)2173-973516